As of September 2024, Xbrane Biopharma AB has a market cap of $401.35K. This makes Xbrane Biopharma AB the world's th valuable company by market cap, according to our data. The market capitalization, also known as a stock market cap is a key financial indication. It represents the combined worth of all the outstanding shares of a publicly traded company multiplied by the current stock price. This figure is often used to see how much a company is worth. This figure is often used to see what is the company net worth.
Year | Market Cap | Change |
---|---|---|
2024 | $6.92M | -76.20% |
2023 | $29.08M | -87.82% |
2022 | $238.77M | -21.66% |
2021 | $304.79M | 40.11% |
2020 | $217.54M | 116.18% |
2019 | $100.63M | -20.49% |
2018 | $126.55M | -30.19% |
2017 | $181.28M | 62.35% |
2016 | $111.67M | - |